Heart development in vivo and cardiomyocyte differentiation in vitro
To understand how cardiomyocytes differentiate from ESCs/iPSCs, comparison between embryo and ESC/iPSC differentiation would be helpful. In this section, we describe how a heart develops in an embryo, and how cardimyocytes differentiate from ESCs/iPSCs. (Figure 1 and 2) 
Heart development in vivo
The heart is the first functional organ in mammals. After fertilization, a Zygote cleaves and forms blastcyst before implantation (-E3.5), which contains inner cell mass (ICM) and trophoblast. ICM cells develop toward whole body, and ESCs are established from ICM cells. ICM cells segregate to epiblast and primitive endoderm lineages in late blastcyst. In epiblast stage, Part of epiblast cells migrate to midline and form primitive streak under induction of Nodal secreted from node. In primitive streak, Brachyury is expressed. Wnt3a and Wnt5 are secreted in primitive streak and regulate expansion of primitive streak (Takada et al. 1994) . Cells migrating through primitive streak differentiate to mesoderm and endoderm. The outer layer cells are called endoderm that is primordia of intestines, liver, pancreas and so on. The rest cells in epiblast, which do not migrate, are called ectoderm that is primordia of neuronal system and skin. Between the layers of endoderm and ectoderm, mesoderm cells differentiate from primitive streak and loose epithelial markers such as Ecadherin. Part of mesoderm cells migrate to lateral side and are called lateral plate mesoderm (LPM) . LPM expresses Flk1 and Pdgfrα on their surface and Mesp1 that is a transcriptional factor regulating cardiac mesoderm (Kataoka et al., 1997; Saga et al., 2000) . Several secreting factors are known as regulators of LPM and cardiac mesoderm formation. Spatial-temporal expression of Bmp4 regulates mesoderm fate. Anterior visceral endoderm cells secrete Noggin, Cerberus, and Dkk1, which regulate cardiac mesoderm formation thorough inhibition of BMP and Wnt signaling (Foley and Mercola, 2005) . Non canonical Wnt family, Wnt11 is also known to be involved in cardiac mesoderm to heart development (Pandur et al., 2002) . LPM cells migrate anteriorly and forms cardiac crescent, which expresses Nkx2.5 and/or Islet1. Nkx2.5 + population called first heart field and Islet1 + population called second heart field. Cardiac crescent cells migrate and fuse in midline and form heart tube. Then heart tube loops rightward to form four-chambered heart. First heart field mainly contributes to left ventricle and second heart field contributes to atrium and right ventricle.
Cardiomyocyte differentiation in vitro -Embryoid body method
In ESC/iPSC differentiation, EB method is widely used (Figure 1 ). This method is rather easy to differentiate ESC/iPSC toward various cell types. However, it is hard to evaluate exact molecular mechanisms and monitor at single cell level. Using EB method in cardiac differentiation, beating EB in total EB rate is widely used for quantitative evaluation. During differentiation process, some mesoderm (Brachyury, Mesp1, Flk1, and Pdgfra) or cardiac markers (Nkx2.5, Islet1, actinin, αMHC and etc.) are used. These markers were evaluated using RT-PCR or transgenic line in some cases. Other than transgenic line or cell surface antigen, it is hard to evaluate in single cellular level for differentiation step. Some growth factors mentioned above increase cardiac differentiation. Wnt3a have been shown to have stage specific and bi-phasic effect (Naito et al., 2006; Ueno et al., 2007) . Wnt3a treatment increased cardiac differentiation in early stage of differentiation and decreased in late stage. Fig. 1 . Heart development in embryo and cardiac differentiation from ESCs in vitro. Cardiac lineage is mainly differentiate through primitive streak, lateral plate mesoderm, and cardiac crescent. Cardiac crescent cells migrate and fuse at midline of embryo and form heart primordial called heart tube. ESCs are established from inner cell mass of blastcyst. When ESCs are cultured in suspension, they form embryoid body, spontaneously differentiate and start beating when cardiomyocyte appear. Another differentiation method using 2D culture with sequential sorting provide us to understand stage specific prosess of differentiation.
Administration of Wnt11 in late stage of EB increase cardiomyocyte differentiation (Terami et al., 2004) . Short term exposure of Noggin also directed ESCs to cardiac differentiation (Yuasa et al., 2005) . Recently, directed differentiation methods using Activin A and BMP4 in EBs or high density culture of human ESCs were reported (Buehr et al., 2008; Laflamme et al., 2007) . As shown here, some cardiogenic growth factors have been reported similar to embryo development. However these studies are still not clear to show the molecular mechanisms or target cells because of heterogeneity of cells in EBs or high density culture.
Cardiomyocyte differentiation in vitro -Two-dimensional culture and sequential differentiation
To overcome the weak points of EB method, we have developed a novel differentiation method using two-dimensional culture and FACS. In this method, we can systemically induce cardiovascular cells -cardiomyocyte, endothelial cells, pericyte, and hematopoietic cells from single Flk1 positive mesoderm cells (Figure 2 ). Withdrawal of LIF induces ESC/iPSC differentiation. Flk1 + mesoderm cells appear during 4-4.5 days after LIF withdrawal. Flk1 + cells are negative for E-cadherin, an ESC marker, and positive for Pdgfra. As previously reported (Kataoka et al., 1997) , Flk1 + /Pdgfra + cells are observed wedgeshaped areas on proximal lateral mesoderm of mid-late streak stage embryo (E7.0) and are also observed in the anterior head fold region of head fold stage embryos (E7.5-7.75), which might consistent with cardiac crescent. Purified Flk1 + cells give rise to cardiomyocyte after 3-4 days coculture on OP9 feeder cells. Endothelial cells, hematopoietic cells, and pericytes are also observed in Flk1 culture on OP9. At Flkd2, small subset of Flk1 progeny, Flk1 + /CXCR4 + /VE-cadherin -(FCV) cells appear and almost all cardiomyocytes are from this FCV population (Yamashita et al., 2005) . Even single Flk1 + and FCV cells can give rise to all these cardiovascular cells on OP9 feeder cells. Thus, it let us to know how much Flk1 + and FCV cells have the differentiation potentials and to observe differentiation process under time lapse imaging (Eilken et al., 2009) . Using this system, we can determine differentiation stage specific event and target cells. In the heart, there are some subsets of cardiomyocytes, ventricular and atrial cardiomyocytes, conduction system cells, and pacemaker cells. Some molecular markers are known for these cardiomyocytes, such as myosin light chain (Mlc2v and Mlc2a), gap junction protein, and ion channels (Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, L and T type Ca channels, Na channels and K channels). Electrophysiological study clearly distinguishes them in single cellular level. In early differentiation stage (such as Flkd9.5), ESC derived cardiomyocytes show almost homogeneous phenotype, like heart tube stage. Cardiomyocytes have automaticity, higher maximum diastolic potential, and slower maximum stroke velocity (dV/dt). On the other hand, in late differentiation stage (such as Flkd23.5), cardiomyocytes show diverse character -(1) automaticity+, higher maximum diastolic potential and slower dV/dt (2) automaticity-, deep resting membrane potential, and faster dV/dt (Yanagi et al., 2007) .
2D culture for EC differentiation
Flk1 positive cells are also able to differentiate to endothelial cells and pericyte on collagen IV dish with VEGF or in Collagen gel as well as on OP9 cells (Yamashita et al., 2000) . Administration of cAMP with VEGF enhanced arterial endothelial cell differentiation (YurugiKobayashi et al., 2006) . Furthermore, this system clearly reconstituted downstream signals of cAMP. PKA enhance endothelial differentiation through enhancing VEGF signaling by Yamashita et al., 2005) up-regulation of Flk1 and Nrp1, which forms VEGF receptor complex (Yan et al., 2009 ). Addministration of cAMP also activate Notch and β-catenin, which form transcriptional complex to increase arterial endothelial cell differentiation (Yamamizu et al., 2010) .
Chemical biology in stem cell biology
ESC Differentiation methods have been developed based on embryology as described above. Recently, combined with chemical biology, it has come to next stage. In this section, we review chemical biology and show some examples of chemical biology combined with stem cell biology
What is chemical biology?
Chemical biology or chemical genetics is the study to elucidate biological systems with small molecules that bind directly to proteins to alter protein function. There are two ways of chemical biology: forward chemical genetics and reverse chemical genetics similar to conventional genetics. "Forward" means phenotype based, so random mutation is used in conventional genetics and screenings of small molecules, which induce phenotype of interest, are used in chemical genetics. "Reverse" means target based, so that gene-targeting and transgenic animals, and RNA interference technologies are used in conventional genetics, and target-specific small molecules, such as kinase inhibitors, are used in chemical genetics. The concept itself is not so much different; however, chemical genetics have great advantages and some disadvantages compared to conventional method. Small molecules have great advantages in temporal control, rapid inhibition or activation, and regulation of functionally overlapping targets, compared to conventional method. However, they also have some disadvantages in target specificity and off-target effect. To verify or confirm the targets of small molecules are more difficult. When chemical biology is combined with stem cell biology, some screening system is required to screen chemical libraries. High throughput screening (HTS) is one of conventional and highly efficient method to screen chemicals, in which such as plate reader is used to measure biological output (luciferase activity, etc.). Recent advances of imaging system provide a novel screening method, named high content screening (HCS), which is based on microscopes. In HCS, immunostained wells are photographed and scored using computer automatically to measure immunoreactive area or to count number of cells that show appropriate phenotypes.
Chemical biology in cardiomyocyte differentiation
In this section, we describe some example of cardiogenic small molecules. Ascorbic acid is a firstly identified chemical that increased cardiomyocyte differentiation from ESC (Takahashi et al., 2003) . Ascorbic acid was identified from "The FDA2000 Drug Library", which contains 880 of bioactive compounds approved for human use. In this screen, the authors used an ESC line carring αMHC-EGFP. The only compound found to reproducibly induce differentiation in monolayer culture was ascorbic acid. Interstingly, ascorbic acid showed no significant effect in cardiac differentiation using EB formation. Cardiogenol was identified from 100,000 compound library using P19, embryonic carcinoma cell line, stably transfected rat atrial natiuretic factor promoter-luciferace (ANF-luc) vecter (Wu et al., 2004) . In this ANF-luc reporter assay, Approximately 80 compounds were identified and 35 of 80 compounds induced MHC expression in P19CL6. 4 diaminopyrimidines, cardiogenol A-D were the most potent in inducing MHC expression.
Wu et al. also tested R1, a mouse ESC line, to confirm the effects of cardiogenol. R1 cells were cultured in extremely high density (10,000cells/well in gelatin coarted 384-well plate) with cardiogenol treatment in first 3 days of 7 days culture period. Although the authors did not mention about the molecular machineries or differentiation stage specificity, R1 cells were treated in early differentiation stage indicating cardiogenol may induce cardiogenic mesoderm. Sulfonylhydrazone (Shz-1) was identified from 147,000 compund library using P19CL6, stably transfected bacterial artificial chromosome (BAC) of Nkx2.5 locus, which luciferase is knocked-in (Nkx2.5-luc) (Sadek et al., 2008) . 3,000 strong positive hits from the primary screen were selected and 1,600 compounds were still positive for the secondary screen using dose response strategy. The authors clustered these hits into 10 lists of families with chemically distinct, synthetically tractable core structural motifs. Shz was one of the strongest lead chemicals. 48 hr treatment of Szh-1 at 5μM increased Nkx2.5-luc activity and 72hr Shz1 treatment increased sarcomeric α-tropomyosin expression in P19CL6. They also tested SM1 ES cells. Because 48hr after treatment of Shz-1 endogenous myocardin and Brachyury expression level was increased, Shz-1 might also increase cardiac mesoderm differentiation. They tested various signal cascades to indentify Shz-1 target molecules but failed. They also demonstrated Shz1 increased cardiac differentiation from human MPBMCs in vitro. Shz1 treated M-PBMCs rescued Cryoinjured rat heart. Tgfbr1 inhibitor was identified as an alternative of Sox2 transgenes in generation of iPSCs from 800 compounds (Ichida et al., 2009 ). BIX01294 (G9a/GLP inhibitor), BayK8644 (L type Ca channel agonist) and RG108 (Dnmt inhibitor) were also identified that they could enhance reprogramming through screening of 2,000 bioactive molecules. These chemicals are identified through phenotype-based screening, so that forward chemical genetics was used for identification of them. Using reverse chemical genetics, some important findings for maintenance and generation of ESCs/iPSCs were reported. As FGF4/ERK signaling is a promoter signal to induce differentiation of mouse ESCs, inhibition of FGF4/ERK using SU5402 and PD184352 suppressed ESC differentiation without LIF. In this condition, apoptosis was relatively high.
To reduce apoptosis and increase ESC growth, CHIR99021 a specific GSK3 inhibitor was combined with SU5402 and PD184352. This three-inhibitor combination SU5402+PD184352+CHIR99021 (3i) support the maintenance of ESCs without Stat3 that is indispensable downstream target of LIF . Furthermore, 3i supported to generate rat ESCs (Buehr et al., 2008) . Generating iPSCs is robustly studied using small molecules such as 5-azacitidine (Mikkelsen et al., 2008) , valproic acid (Huangfu et al., 2008) and TGFβ inhibitor (Lin et al., 2009 ) with reverse genetics to elucidate the machineries of reprogramming.
Chemical biology in other lineage differentiation
As like cardiogenic chemicals and small molecules for maintenance and generation of ESC/iPSC, Douglas A. Melton and his colleagues reported some small molecules induce definitive endoderm and pancreatic lineage differentiation using HCS Chen et al., 2009 ). Inducers of definitive endoderm (IDE) 1 and 2 were identified from 4,000 
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compounds using Sox17-dTomato mESC line to replace Activin A for the initial induction of endoderm. IDE-1 and 2 transactivate TGFβ/Activin A/nodal signaling through unknown machinery. (-)-Indolactam V was identified from 5,000 compounds as inducing differentiation of Pdx1 + pancreatic progenitor from definitive endoderm derived from human ESCs using high content screening. Activation of PKC signaling is the major pathway of the induction of Pdx1+ pancreatic progenitor using Indolactam V.
An immunosuppressant cyclosporin-A induced cardiac progenitor and cardiomyocyte differentaion
We reported cyclosporin-A, an immunosuppressant specifically and efficiently induce cardiac progenitors and cardiomyocytes from mesoderm cells (Yan et al., 2009) . In this section, we summarize our results (Figure 3 and 4) .
CsA induced cardiac progenitors and cardiomyocyte differentiation from mesoderm cells.
Addition of CsA (1-3μg/mL) to Flk1 + cells on OP9 showed a striking effect to increase cardiomyocyte differentiation at Flkd6. Cardiac troponin T positive area was increased more than 10 times and 60% of Flk1 + cell-derived cells became αMHC-GFP + cardiomyocytes in maximum. To clarify stage specificity, we added CsA during the differentiation stage of undifferentiated ESC-Flkd0, Flkd0-d2, and Flkd2-d6. CsA most potently showed the cardiogenic effect during Flkd0-2. Thus, we evaluated CsA effect on FCV cardiac progenitor differentiation and demonstrated that CsA treatment potently increased cardiac progenitor differentiation more than 20 times. Interestingly, CsA treatment strongly suppressed endothelial or hematopoietic differentiation suggesting that CsA may shift the cell fate from hemangiogenic to cardiogenic.
Character, expanded cardiac progenitor
Expanded FCV progenitor cells express Flk1, Cxcr4, Gata4, Nkx2.5, and Islet1 but not myosin chains nor ion channels. Nkx2.5 and Islet1 are the markers for the first and second heart field respectively, which were reported as cardiac progenitor markers in ESC differentiation (Moretti et al., 2006; Wu et al., 2006) . In FCV cells, approximately 24% of FCV cells were positive for Nkx2.5, 42% were positive Islet1, and 14% were double positive for Nkx2.5 and Islet1. This efficient expansion of the rare FCV progenitor cells allowed us to confirm their cardiogenic potential in vivo. We performed transplantation of CsA-induced FCV cells to rat chronic myocardial infarction model. At 2 weeks after the injection, transplanted FCV cells were successfully differentiated into cardiomyocytes and integrated in the infarct heart. This result indicates that CsA-expanded FCV cells can show highly cardiogenic potentials also in vivo after cell transplantation. Cardiomyocytes induced using CsA express various cardiac markers such as Gata4, Tbx3, Nkx2.5, Islet1 and multiple myosin chains. Cardiomyocytes also have apparent sarcomere structure, and pacemaker like potential with spontaneous beating or quiescent ventricular type potential. NFAT signal inhibitors -FK506, VIVID (NFAT inhibitor) and cypermethrin. All of NFAT inhibitors failed to induce cardiomyocyte differentiation. On the other hand, NFAT inhibitors strongly inhibited endothelial differentiation. These results indicate that CsA effect on cardiomyocyte induction is through unknown pathway, and CsA effect on endothelial induction is through NFAT signaling.
Molecular mechanism of cyclosporin A

Extension to HTS and HCS
The finding of CsA prompted us to apply our system to HTS and/or HCS ( Figure 5 ). We first developed HTS using αMHC-GFP ESCs to determine cardiac differentiation. We found this system could work but it showed high background signals and low signals to noise ratio because of lower dynamic range of GFP (Willems et al., 2009) . Thus, to validate the result we needed to reanalyze using immunostaining or flow cytometry. We then developed HCS using αMHC-GFP and cTnT staining, next. HCS required us some development for imaging and analyzing for the assay and it took much more time for staining and imaging than HTS. As expected, it showed lower background and higher signal to noise ratio than HTS. The balance between the data quality and cost and/or time should be considered to choose HTS or HCS.
Recently we have identified novel cardiogenic effects of natural compounds that strongly promote cardiac differentiation from Flk1 + mesoderm cells using this HTS combined with HCS for validation of the results (Fukushima et al., unpublished) . We also have identified some cardiomyocyte proliferating chemicals using HCS to directly count cardiomyocyte number and analyze cell cycle (Uosaki et al., unpublished).
Conclusion
Cardiac development in vivo and in vitro, chemical biology combined with stem cells, and comparison of HTS and HCS are described here. In chemical biology, it is of course important to identify and clarify how chemicals work and what molecular mechanisms are. Indeed it is difficult in some case, chemical biology would greatly improve and accelerate stem cell biology, which has been based on embryonic development.
